作者
Marianthi Karali,Gema García‐García,Karolina Kamińska,Alaa AlTalbishi,Francesca Cancellieri,Francesco Testa,Maria Rosaria Barillari,Evangelia S. Panagiotou,George Psillas,Veronika Vaclavik,Hoai Viet Tran,Lucas Janeschitz‐Kriegl,Hendrik P. N. Scholl,Manar Salameh,Pilar Barberán-Martínez,Ana Rodríguez‐Muñoz,Miguel Armengot,Margherita Scarpato,Roberta Zeuli,Mathieu Quinodoz,Francesca Simonelli,Carlo Rivolta,Sandro Banfi,José M. Millán
摘要
Abstract The AGBL5 gene encodes for the Cytoplasmic Carboxypeptidase 5 (CCP5), an α-tubulin deglutamylase that cleaves the γ-carboxyl-linked branching point of glutamylated tubulin. To date, pathogenic variants in AGBL5 have been associated only with isolated retinitis pigmentosa (RP). Hearing loss has not been reported in AGBL5 -caused retinal disease. In this study, we performed exome sequencing in probands of eight unrelated families from Italy, Spain, Palestine, Switzerland, and Greece. All subjects had a clinical diagnosis of (suspected) Usher syndrome type II for the concurrent presence of RP and post-verbal sensorineural hearing loss (SNHL) that ranged from mild to moderate.We identified biallelic sequence variants in AGBL5 in all analysed subjects. Four of the identified variants were novel. The variants co-segregated with the retinal and auditory phenotypes in additional affected family members. We did not detect any causative variants in known deafness or Usher syndrome genes that could explain the patients’ hearing loss. We therefore conclude that SNHL is a feature of a syndromic presentation of AGBL5 retinopathy. This study provides the first evidence that mutations in AGBL5 can cause syndromic RP forms associated with hearing loss, probably due to dysfunction of sensory cilia in the retina and the inner ear.